10/10/2024CDE Issues the Technical Guidelines for the Analysis and Handling of S...

10/10/2024Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...

10/10/2024Mainland China's Pharmaceutical Sales to Reach $345B by 2033: BMI/Fitc...

10/10/2024Leads Biolabs Receives Breakthrough Therapy Designation in China for E...

10/10/2024Bio-Thera Secures $110M Drug Licensing Deal with Hungary's Gedeon Rich...

10/9/2024NMPA Announces Package Insert Revision of Mezlocillin Sodium Containin...

10/9/2024Bayer Launches Life Sciences Incubator in Shanghai

10/9/2024US Venture Capital Opens Funding Opportunities for China Biotech Firms

10/9/2024SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023

10/9/2024IQVIA Releases the 2024 White Paper on Development Trends in China's O...

10/8/2024MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...

10/8/2024AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...

10/8/2024Innovent and Ask Pharm Enter Strategic Deal for Limertinib 

10/8/2024Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...

10/8/2024Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor

10/8/2024BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...

10/8/2024China to Establish a Unified Mapping Database for Traceability Codes, ...

10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...

10/8/2024Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...

10/8/2024BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...

10/8/2024CDE Issues the List of Reference Formulations for GQCE Studies (83rd B...

10/8/2024CSPC Announces Regulatory Milestones in China and the U.S.

10/8/2024AstraZeneca Expanding R&D pipeline in China

10/8/2024Aadi Bio Wins Arbitration, Rejecting Multimillion-Dollar Claim from Ch...

10/8/2024CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...

10/8/2024China Grants Conditional Approval to Biogen's ALS Therapy Qalsody

10/8/2024NRDL China: 2024 Outlook (Simon Kucher)

10/3/2024WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT

10/3/2024Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...

10/3/2024Recent Executive Moves

Page:58/786 Total number of articles:23558: [First][<<] [56] [57] [58] [59] [60] [>>] [End]